The role of the UPS in cystic fibrosis

BMC Biochemistry

Volumn 8, Issue SUPPL. 1, 2007, Pages

  Turnbull, Emma L ^a   Rosser, Meredith F N ^a   Cyr, Douglas M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; CFPOT 532; CORR 3A; CORR 4A; CURCUMIN; OMEPRAZOLE; PROTEASOME; TRANSMEMBRANE CONDUCTANCE REGULATOR; UBIQUITIN; VRT 325; CFTR PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE INHERITANCE; COMPLEX FORMATION; CYSTIC FIBROSIS; DRUG MECHANISM; GENE MUTATION; HUMAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; REVIEW; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 38449087466     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-8-S1-S11     Document Type: Review

References (88)

1. Identification of the cystic fibrosis gene: chromosome walking and jumping. J.M. Rommens, Science 1989 245 4922 1059 65 10.1126/science.2772657 2772657
2. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. J.R. Riordan, Science 1989 245 4922 1066 73 10.1126/science.2475911 2475911
3. The amino-terminal portion of CFTR forms a regulated Cl- channel. D.N. Sheppard, Cell 1994 76 6 1091 8 10.1016/0092-8674(94)90385-9 7511062
4. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. S.M. Kreda, Mol Biol Cell 2005 16 5 2154 67 15716351 10.1091/mbc.E04-11-1010
5. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis. G.M. Roomans, Am J Respir Med 2003 2 5 413 31 14719993
6. Tiny dancers: the integrin-growth factor nexus in angiogenic signaling. S.S. Smyth C. Patterson, J Cell Biol 2002 158 1 17 21 10.1083/jcb.200202100 12105178
7. The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. G.C. Meacham, Embo J 1999 18 6 1492 505 10075921 10.1093/emboj/18.6.1492
8. Association of domains within the cystic fibrosis transmembrane conductance regulator. L.S. Ostedgaard, Biochemistry 1997 36 6 1287 94 10.1021/bi962174s 9063876
9. Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. X. Xiong, J Clin Invest 1997 100 5 1079 88 9276724
10. A new gun in town: the U box is a ubiquitin ligase domain. C. Patterson, Sci STKE 2002 2002 116 PE4 11805346
11. Folding of CFTR is predominantly cotranslational. B. Kleizen, Mol Cell 2005 20 2 277 87 10.1016/j.molcel.2005.09.007 16246729
12. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. M.S. Gelman R.R. Kopito, J Clin Invest 2002 110 11 1591 7 12464661 10.1172/JCI200216786
13. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. G.L. Lukacs, Embo J 1994 13 24 6076 86 7529176
14. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. C.L. Ward R.R. Kopito, J Biol Chem 1994 269 41 25710 8 7523390
15. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. T.J. Jensen, Cell 1995 83 1 129 35 10.1016/0092-8674(95)90241-4 7553864
16. COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code. X. Wang, J Cell Biol 2004 167 1 65 74 10.1083/jcb.200401035 15479737
17. Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway. J.S. Yoo, J Biol Chem 2002 277 13 11401 9 10.1074/jbc.M110263200 11799116
18. Cystic fibrosis. S.M. Rowe S. Miller E.J. Sorscher, N Engl J Med 2005 352 19 1992 2001 10.1056/NEJMra043184 15888700
19. Novel, mechanism-based therapies for cystic fibrosis. R.C. Rubenstein, Curr Opin Pediatr 2005 17 3 385 92 10.1097/01.mop.0000158846.95469.6f 15891431
20. Cystic fibrosis: genotypic and phenotypic variations. J. Zielenski L.C. Tsui, Annu Rev Genet 1995 29 777 807 10.1146/annurev.ge.29.120195.004021 8825494
21. Arrest of CFTRDeltaF508 folding. D.M. Cyr, Nat Struct Mol Biol 2005 12 1 2 3 10.1038/nsmb0105-2 15689966
22. Degradation of CFTR by the ubiquitin-proteasome pathway. C.L. Ward S. Omura R.R. Kopito, Cell 1995 83 1 121 7 10.1016/0092-8674(95)90240-6 7553863
23. Aggresomes: a cellular response to misfolded proteins. J.A. Johnston C.L. Ward R.R. Kopito, J Cell Biol 1998 143 7 1883 98 10.1083/jcb.143.7.1883 9864362
24. Evidence that endoplasmic reticulum (ER)-associated degradation of cystic fibrosis transmembrane conductance regulator is linked to retrograde translocation from the ER membrane. X. Xiong E. Chong W.R. Skach, J Biol Chem 1999 274 5 2616 24 10.1074/jbc.274.5.2616 9915789
25. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. M.S. Gelman E.S. Kannegaard R.R. Kopito, J Biol Chem 2002 277 14 11709 14 10.1074/jbc.M111958200 11812794
26. The ubiquitin-proteasome pathway: on protein death and cell life. A. Ciechanover, Embo J 1998 17 24 7151 60 9857172 10.1093/emboj/17.24.7151
27. Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. T. Hoppe, Trends Biochem Sci 2005 30 4 183 7 10.1016/j.tibs.2005.02.004 15817394
28. Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. D.M. Cyr J. Hohfeld C. Patterson, Trends Biochem Sci 2002 27 7 368 75 10.1016/S0968-0004(02)02125-4 12114026
29. The regulation of proteasome degradation by multi-ubiquitin chain binding proteins. J. Miller C. Gordon, FEBS Lett 2005 579 15 3224 30 10.1016/j.febslet.2005.03.042 15943965
30. Lingering mysteries of ubiquitin-chain assembly. M. Hochstrasser, Cell 2006 124 1 27 34 10.1016/j.cell.2005.12.025 16413479
31. Ubiquitin and ubiquitin-like proteins as multifunctional signals. R.L. Welchman C. Gordon R.J. Mayer, Nat Rev Mol Cell Biol 2005 6 8 599 609 10.1038/nrm1700 16064136
32. Recognition of the polyubiquitin proteolytic signal. J.S. Thrower, Embo J 2000 19 1 94 102 10619848 10.1093/emboj/19.1.94
33. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. G.C. Meacham, Nat Cell Biol 2001 3 1 100 5 10.1038/35050509 11146634
34. A foldable CFTR{Delta}F508 biogenic intermediate accumulates upon inhibition of the Hsc70-CHIP E3 ubiquitin ligase. J.M. Younger, J Cell Biol 2004 167 6 1075 85 10.1083/jcb.200410065 15611333
35. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. J.M. Younger, Cell 2006 126 3 571 82 10.1016/j.cell.2006.06.041 16901789
36. From the cradle to the grave: molecular chaperones that may choose between folding and degradation. J. Hohfeld D.M. Cyr C. Patterson, EMBO Rep 2001 2 10 885 90 11600451 10.1093/embo-reports/kve206
37. CHIP: a link between the chaperone and proteasome systems. H. McDonough C. Patterson, Cell Stress Chaperones 2003 8 4 303 8 15115282 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2
38. CHIP: a quality-control E3 ligase collaborating with molecular chaperones. S. Murata T. Chiba K. Tanaka, Int J Biochem Cell Biol 2003 35 5 572 8 10.1016/S1357-2725(02)00394-1 12672450
39. The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. S. Alberti, Mol Biol Cell 2004 15 9 4003 10 15215316 10.1091/mbc.E04-04-0293
40. BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. V. Arndt, Mol Biol Cell 2005 16 12 5891 900 16207813 10.1091/mbc.E05-07- 0660
41. Regulation of the Cytoplasmic Quality Control Protein Degradation Pathway by BAG2. Q. Dai, J Biol Chem 2005 280 46 38673 38681 10.1074/jbc.M507986200 16169850
42. Post-translational disruption of the delta ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta ΔF508 CFTR in the rabbit reticulocyte lysate. W. Fuller A.W. Cuthbert, J Biol Chem 2000 275 48 37462 8 10.1074/jbc.M006278200 10982807
43. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. S.H. Cheng, Cell 1990 63 4 827 34 10.1016/0092-8674(90)90148-8 1699669
44. Induction of HSP70 promotes DeltaF508 CFTR trafficking. L.R. Choo-Kang P.L. Zeitlin, Am J Physiol Lung Cell Mol Physiol 2001 281 1 L58 68 11404246
45. Derlin-1 promotes the efficient degradation of CFTR and CFTR folding mutants. F. Sun, J Biol Chem 2006
46. Inaugural Article: Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Y. Ye, Proc Natl Acad Sci U S A 2005 102 40 14132 8 16186510 10.1073/pnas.0505006102
47. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. B.N. Lilley H.L. Ploegh, Proc Natl Acad Sci U S A 2005 102 40 14296 301 16186509 10.1073/pnas.0505014102
48. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Y. Ye, Nature 2004 429 6994 841 7 10.1038/nature02656 15215856
49. The Ubiquitin-domain Protein HERP forms a Complex with Components of the Endoplasmic Reticulum Associated Degradation Pathway. A. Schulze, J Mol Biol 2005 16289116
50. Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation. C. Schuberth A. Buchberger, Nat Cell Biol 2005 7 10 999 1006 10.1038/ncb1299 16179952
51. The retrotranslocation protein Derlin-1 binds peptide: N-glycanase to the endoplasmic reticulum. S. Katiyar S. Joshi W.J. Lennarz, Mol Biol Cell 2005 16 10 4584 94 16055502 10.1091/mbc.E05-04-0345
52. RMA1, an Arabidopsis thaliana gene whose cDNA suppresses the yeast sec15 mutation, encodes a novel protein with a RING finger motif and a membrane anchor. N. Matsuda A. Nakano, Plant Cell Physiol 1998 39 5 545 54 9664717
53. Rma1, a novel type of RING finger protein conserved from Arabidopsis to human, is a membrane-bound ubiquitin ligase. N. Matsuda, J Cell Sci 2001 114 Pt 10 1949 57 11329381
54. A role for mammalian Ubc6 homologues in ER-associated protein degradation. U. Lenk, J Cell Sci 2002 115 Pt 14 3007 14 12082160
55. Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. M. Knop, Embo J 1996 15 4 753 63 8631297
56. A membrane protein required for dislocation of misfolded proteins from the ER. B.N. Lilley H.L. Ploegh, Nature 2004 429 6994 834 40 10.1038/nature02592 15215855
57. Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. A. Gnann J.R. Riordan D.H. Wolf, Mol Biol Cell 2004 15 9 4125 35 15215312 10.1091/mbc.E04-01- 0024
58. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. C.C. Weihl, Hum Mol Genet 2006 15 2 189 99 10.1093/hmg/ddi426 16321991
59. Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways. T. Ravid S.G. Kreft M. Hochstrasser, Embo J 2006 25 3 533 43 16437165 10.1038/sj.emboj.7600946
60. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. N. Vij S. Fang P.L. Zeitlin, J Biol Chem 2006 281 25 17369 78 10.1074/jbc.M600509200 16621797
61. Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. S. Dalal, Mol Biol Cell 2004 15 2 637 48 14617820 10.1091/mbc.E03-02-0097
62. Cystic fibrosis transmembrane conductance regulator as a model substrate to study endoplasmic reticulum protein quality control in mammalian cells. J.M. Younger, Methods Mol Biol 2005 301 293 303 15917641
63. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. D.N. Sheppard, Am J Physiol 1994 266 4 Pt 1 L405 13 7513963
64. Murine epithelial cells: isolation and culture. D.J. Davidson, J Cyst Fibros 2004 3 Suppl 2 59 62 10.1016/j.jcf.2004.05.013 15463928
65. Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. D.C. Devor R.J. Bridges J.M. Pilewski, Am J Physiol Cell Physiol 2000 279 2 C461 79 10913013
66. Cystic fibrosis mouse models. C. Guilbault, Am J Respir Cell Mol Biol 2007 36 1 1 7 10.1165/rcmb.2006-0184TR 16888286
67. Species-specific differences in mouse and human airway epithelial biology of recombinant adeno-associated virus transduction. X. Liu, Am J Respir Cell Mol Biol 2006 34 1 56 64 16195538 10.1165/rcmb.2005-0189OC
68. A mouse model for the cystic fibrosis delta ΔF508 mutation. J.H. van Doorninck, Embo J 1995 14 18 4403 11 7556083
69. Generation and characterization of a delta F508 cystic fibrosis mouse model. W.H. Colledge, Nat Genet 1995 10 4 445 52 10.1038/ng0895-445 7545494
70. A mouse model for the delta F508 allele of cystic fibrosis. B.G. Zeiher, J Clin Invest 1995 96 4 2051 64 7560099
71. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. J.R. Dorin, Gene Ther 1996 3 9 797 801 8875228
72. Analysis of ClC-2 channels as an alternative pathway for chloride conduction in cystic fibrosis airway cells. E.M. Schwiebert, Proc Natl Acad Sci U S A 1998 95 7 3879 84 9520461 10.1073/pnas.95.7.3879
73. ClC-2 Cl- channels in human lung epithelia: activation by arachidonic acid, amidation, and acid-activated omeprazole. J. Cuppoletti, Am J Physiol Cell Physiol 2001 281 1 C46 54 11401826
74. Genistein potentiates wild-type and delta F508-CFTR channel activity. T.C. Hwang, Am J Physiol 1997 273 3 Pt 1 C988 98 9316420
75. Modulation of CFTR chloride channels by calyculin A and genistein. I.C. Yang, Am J Physiol 1997 272 1 Pt 1 C142 55 9038820
76. Genistein, a specific inhibitor of tyrosine-specific protein kinases. T. Akiyama, J Biol Chem 1987 262 12 5592 5 3106339
77. cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. B. Illek, Am J Physiol 1995 268 4 Pt 1 C886 93 7537452
78. Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains. O. Moran L.J. Galietta O. Zegarra-Moran, Cell Mol Life Sci 2005 62 4 446 60 10.1007/s00018-004-4422-3 15719171
79. A quantitative description of the activation and inhibition of CFTR by potentiators: Genistein. O. Moran O. Zegarra-Moran, FEBS Lett 2005 579 18 3979 83 10.1016/j.febslet.2005.06.026 15996659
80. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones. Y. Wang, Mol Pharmacol 2006 70 1 297 302 16624886
81. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. F. Van Goor, Am J Physiol Lung Cell Mol Physiol 2006 290 6 L1117 30 10.1152/ajplung.00169.2005 16443646
82. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. N. Pedemonte, J Clin Invest 2005 115 9 2564 71 16127463 10.1172/JCI24898
83. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. M.E. Egan, Science 2004 304 5670 600 2 10.1126/science.1093941 15105504
84. 2-(dialkylamino)-4H-1-benzopyran-4-one derivatives modify chloride conductance in CFTR expressing cells. M. Mazzei, Farmaco 2003 58 9 961 70 10.1016/S0014-827X(03)00155-1 13679192
85. Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. Y. Song, J Biol Chem 2004 279 39 40629 33 10.1074/jbc.M407308200 15280357
86. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. A. Dragomir, Biochem Biophys Res Commun 2004 322 2 447 51 10.1016/j.bbrc.2004.07.146 15325250
87. Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. T.W. Loo M.C. Bartlett D.M. Clarke, Biochem Biophys Res Commun 2004 325 2 580 5 10.1016/j.bbrc.2004.10.070 15530432
88. The chemical chaperone CFcor-325 repairs folding defects in the transmembrane domains of CFTR-processing mutants. T.W. Loo, Biochem J 2006 395 3 537 42 16417523 10.1042/BJ20060013